What are prescription quit-smoking medicines?

01

Names in guidance and prescriptions are different layers

WHO’s 2024 adult guideline announcement names varenicline, bupropion, cytisine and NRT as pharmacological options. This is an international evidence statement, not confirmation that all are prescription-only or currently available in every country. US FDA information describes bupropion and varenicline as prescription pills. Even an NRT form can have a different supply category across markets.

[1][2][3]

02

What “non-nicotine medicine” means

The pills described by CDC do not supply replacement nicotine. Varenicline acts at the brain sites to which nicotine binds: it partly stimulates them and reduces nicotine’s effects there. Bupropion works through other brain effects; sharing a cessation purpose does not make the two drugs interchangeable. The explanation identifies broad mechanisms, not a way to predict a personal response or choose treatment.

[2]

03

What an actual prescription must clarify

Ask which exact product is proposed, which current local product information applies, and who will review concerns or changes in smoking. The prescriber needs clinical context and other medicines; the pharmacist can clarify the dispensed product and instructions. A brand name remembered from a foreign article or a past prescription does not establish a current authorised indication.

A medicine may also have uses outside cessation. Do not assume a familiar name has the same formulation, purpose or instructions in a different prescription. Ask the clinician to explain the benefit–risk discussion and the follow-up contact; this page supplies no starting plan, dose, substitution or combination.

[3][4]